Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia

Clin Chem. 1995 Mar;41(3):439-43.

Abstract

Hepatocellular carcinoma (HC) is often difficult to distinguish from secondary liver neoplasia (SLN) by physical and imaging diagnostic procedures alone. To this aim we have extended and improved a laboratory approach based on a serum lactate dehydrogenase isoenzyme ratio (LD4:LD5) by adding the carcinoembryonic antigen: alpha-fetoprotein ratio, alkaline phosphatase, and serum iron concentrations to obtain a highly efficient discriminant function. In two successive cohorts, for a total of 102 patients, all histologically diagnosed, with a prevalence of HC vs SLN of 3:1, we correctly classified 96% of cases (100% of SLN cases). Subsequent verification with the jackknife reallocation statistical algorithm confirmed these results. In conclusion, this discriminant function based on simple laboratory assays of a few analytes is an important tool in solving a diagnostic dilemma in cases of liver neoplasia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / blood
  • Biomarkers, Tumor / blood*
  • Carcinoembryonic Antigen / analysis
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / diagnosis*
  • Diagnosis, Differential
  • Humans
  • Iron / blood
  • Isoenzymes
  • L-Lactate Dehydrogenase / blood
  • Liver Neoplasms / blood
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / secondary*
  • ROC Curve
  • alpha-Fetoproteins / analysis

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Isoenzymes
  • alpha-Fetoproteins
  • Iron
  • L-Lactate Dehydrogenase
  • Alkaline Phosphatase